Drug–Drug Interactions of a Novel κ-Opioid Receptor Agonist, Nalfurafine Hydrochloride, Involving the P-Glycoprotein

被引：0
|
作者：
Akihiro Ando
Shinichiro Sasago
Yoshihiro Ohzone
Yohei Miyamoto
机构：
[1] Toray Industries,Pharmaceutical Clinical Research Department
[2] Inc.,Department of Bio Research
[3] Kamakura Techno-Science,ADME & Tox. Research Institute
[4] Inc.,undefined
[5] Sekisui Medical Co.,undefined
[6] Ltd.,undefined
来源：
European Journal of Drug Metabolism and Pharmacokinetics | 2016年 / 41卷
关键词：
Digoxin; Verapamil; Sodium Dihydrogen Phosphate; Organic Modifier Content; Uremic Pruritus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：549 / 558
页数：9
相关论文
共 50 条
  • [41] Induction of P-glycoprotein expression and activity by Aconitum alkaloids: Implication for clinical drug-drug interactions
    Wu, Jinjun
    Lin, Na
    Li, Fangyuan
    Zhang, Guiyu
    He, Shugui
    Zhu, Yuanfeng
    Ou, Rilan
    Liu, Shuqiang
    Feng, Lizhi
    Liu, Liang
    Liu, Zhongqiu
    Lu, Linlin
    SCIENTIFIC REPORTS, 2016, 6
  • [42] Study of drug interactions with efflux pumps using P-glycoprotein containing membranes
    Xia, CQ
    Liu, N
    Gan, LS
    Miwa, G
    DRUG METABOLISM REVIEWS, 2003, 35 : 151 - 151
  • [43] P-glycoprotein related drug interactions: clinical importance and a consideration of disease states
    Lee, Caroline A.
    Cook, Jack A.
    Reyner, Eric L.
    Smith, Dennis A.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2010, 6 (05) : 603 - 619
  • [44] RECONSTITUTION OF DRUG TRANSPORT BY PURIFIED P-GLYCOPROTEIN
    SHAPIRO, AB
    LING, V
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (27) : 16167 - 16175
  • [45] Importance of P-glycoprotein for drug disposition in humans
    Fromm, MF
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2003, 33 : 6 - 9
  • [46] P-Glycoprotein Targeted Nanoscale Drug Carriers
    Li, Wengang
    Abu Samra, Dina
    Merzaban, Jasmeen
    Khashab, Niveen M.
    JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2013, 13 (02) : 1399 - 1402
  • [47] Role of P-glycoprotein in drug metabolism and disposition
    Lin, JH
    DRUG METABOLISM REVIEWS, 2003, 35 : 13 - 13
  • [48] The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter
    Romsicki, Y
    Sharom, FJ
    BIOCHEMISTRY, 1999, 38 (21) : 6887 - 6896
  • [49] Toxic digoxin-drug interactions: The major role of renal p-glycoprotein
    Koren, G
    Woodland, C
    Ito, S
    VETERINARY AND HUMAN TOXICOLOGY, 1998, 40 (01) : 45 - 46
  • [50] P-glycoprotein system as a determinant of drug interactions: The case of digoxin-verapamil
    Verschraagen, M
    Koks, CHW
    Schellens, JHM
    Beijnen, JH
    PHARMACOLOGICAL RESEARCH, 1999, 40 (04) : 301 - 306
12345